Pathway overview
Heart transplantation depends on deceased-donor allocation and highly specialized clinical care. National rules commonly govern listing, priority, residence, and organ allocation.
MedTransplant cannot arrange a donor, secure listing, alter priority, or guarantee that a hospital will accept an international patient.
Important distinctions
- Allocation
- Organ allocation is controlled by authorized national or regional systems.
- Evaluation
- A specialist hospital assesses advanced heart disease, treatment alternatives, and transplant suitability.
- Continuity
- Long-term immunosuppression and specialist follow-up must be feasible after surgery.
Topics a hospital may evaluate
Requirements differ by person, programme, and jurisdiction. A licensed transplant team may consider:
- Advanced heart disease
- Alternative therapies
- Other organ function
- Infection and cancer screening
- Long-term support and follow-up
Questions to ask a licensed transplant hospital
- Which licensed transplant hospital should review my situation?
- Which pathway is legally available to a non-resident in this jurisdiction?
- What evaluation steps and records will the hospital request directly?
- How are donor protection, consent, allocation, and follow-up handled?
